Book Multi-Cancer Early Detection Test (Galleri®) Near Me

The Galleri Multi-Cancer Early-Detection Test

LabFinder is pleased to announce that we now offer the Galleri Multi-Cancer Early-Detection Test*, a single blood test that can screen for multiple cancers. The test is only available at the New York City HEMO locations. *The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. It is intended to be used in addition to, and not replace, other cancer screening tests.

What is the Galleri Test?

• Screens for a signal shared by 50+ cancers, including fast-spreading, aggressive cancers that don't show symptoms in early stages, such as pancreatic and ovarian.
• Looks for signals associated with active cancer but does not predict your future genetic risk for cancer.
• If a cancer signal is detected, Galleri predicts the tissue type or organ associated with the cancer signal.

Who qualifies for the Galleri Test?

This test is recommended for adults with an elevated risk for cancer, such as those aged 50 or older, or with a family history of cancer. Please note use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Talk to us to determine if the test is right for you.

How do I access it?

If you are interested in the Galleri test, please book through LabFinder at a HEMO location. Please note there is a limited supply, so reserve your tests as soon as possible.

How much does it cost?

This test is self pay for $999, which includes doctor's oversight.

Please Note:

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests. Learn more by visiting Blood Test for Cancer Screening | Galleri® or watching this short video. Review Important Safety Information. Labfinder, LLC and Hemo, LLC are not manufacturers of the test kit and make no representation or warranty concerning the product, results, accuracy or efficacy. Consult a qualified healthcare professional for advice.

References

US-GA-2100099-3

1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-

cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806.

Important Safety Information

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Cancer Signal Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g.imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only. Laboratory / Test Information GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

Book on LabFinder: find a lab today on our lab finder and request a test doctor guided.